Initial Case Report of Robot-Assisted Radical Cystectomy With Intracorporeal Neobladder Using hinotori Surgical Robot System

Q4 Medicine

IJU Case Reports Pub Date : 2025-03-12 DOI:10.1002/iju5.70016

Hiromitsu Watanabe, Kyohei Watanabe, Yuto Matsushita, Keita Tamura, Daisuke Motoyama, Atsushi Otsuka, Teruo Inamoto, Hideaki Miyake

{"title":"Initial Case Report of Robot-Assisted Radical Cystectomy With Intracorporeal Neobladder Using hinotori Surgical Robot System","authors":"Hiromitsu Watanabe, Kyohei Watanabe, Yuto Matsushita, Keita Tamura, Daisuke Motoyama, Atsushi Otsuka, Teruo Inamoto, Hideaki Miyake","doi":"10.1002/iju5.70016","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Introduction</h3>\n \n <p>Robot-assisted radical cystectomy (RARC) is becoming the standard treatment for bladder cancer patients. While this surgery using da Vinci has been widely reported, this report describes the initial experience of RARC with intracorporeal neobladder using the hinotori surgical robot system.</p>\n </section>\n \n <section>\n \n <h3> Case Presentation</h3>\n \n <p>The patient was a 73-year-old man with muscle-invasive bladder cancer who underwent neoadjuvant chemotherapy followed by RARC with intracorporeal neobladder using hinotori. Surgery was successfully performed with a total operative time of 430 min, time using the robotic system of 375 min, and no intraoperative complications or need for blood transfusion. Postoperative recovery was favorable, with the patient discharged on day 12, and satisfactory continence was achieved.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>This is the initial case report of RARC with intracorporeal neobladder using hinotori, providing a potentially comparable alternative to conventional surgical systems for RARC.</p>\n </section>\n </div>","PeriodicalId":52909,"journal":{"name":"IJU Case Reports","volume":"8 3","pages":"244-248"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/iju5.70016","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"IJU Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/iju5.70016","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction

Robot-assisted radical cystectomy (RARC) is becoming the standard treatment for bladder cancer patients. While this surgery using da Vinci has been widely reported, this report describes the initial experience of RARC with intracorporeal neobladder using the hinotori surgical robot system.

Case Presentation

The patient was a 73-year-old man with muscle-invasive bladder cancer who underwent neoadjuvant chemotherapy followed by RARC with intracorporeal neobladder using hinotori. Surgery was successfully performed with a total operative time of 430 min, time using the robotic system of 375 min, and no intraoperative complications or need for blood transfusion. Postoperative recovery was favorable, with the patient discharged on day 12, and satisfactory continence was achieved.

Conclusions

This is the initial case report of RARC with intracorporeal neobladder using hinotori, providing a potentially comparable alternative to conventional surgical systems for RARC.

Abstract Image

查看原文本刊更多论文

应用hinotori手术机器人系统进行体外新膀胱根治性膀胱切除术首例报告

机器人辅助根治性膀胱切除术（RARC）正在成为膀胱癌患者的标准治疗方法。虽然使用达芬奇的手术已被广泛报道，但本报告描述了使用hinotori手术机器人系统进行体内新膀胱RARC的初步经验。患者是一名73岁男性肌肉浸润性膀胱癌患者，接受了新辅助化疗，随后使用hinotori进行RARC合并体内新膀胱。手术成功完成，总手术时间为430分钟，机器人系统使用时间为375分钟，无术中并发症和输血。术后恢复良好，患者于第12天出院，并获得满意的尿失禁。这是首次报道使用hinotori治疗体外新膀胱RARC的病例，为RARC提供了一种潜在的可与传统手术系统相媲美的替代方案。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊